A new trading day began on Monday, with Merck & Co Inc (NYSE: MRK) stock price down -2.17% from the previous day of trading, before settling in for the closing price of $108.70. MRK’s price has ranged from $99.14 to $134.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.72%. Meanwhile, its annual earnings per share averaged 416.69%. With a float of $2.53 billion, this company’s outstanding shares have now reached $2.53 billion.
Let’s determine the extent of company efficiency that accounts for 72000 employees. In terms of profitability, gross margin is 74.4%, operating margin of 27.3%, and the pretax margin is 24.39%.
Merck & Co Inc (MRK) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Merck & Co Inc is 0.10%, while institutional ownership is 78.96%. The most recent insider transaction that took place on Mar 11 ’24, was worth 492,135,715. In this transaction 10% Owner of this company bought 21,397,205 shares at a rate of $23.00, taking the stock ownership to the 1,000 shares. Before that another transaction happened on Feb 14 ’24, when Company’s EVP & CFO sold 38,291 for $125.50, making the entire transaction worth $4,805,520. This insider now owns 50,908 shares in total.
Merck & Co Inc (MRK) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 416.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.25% during the next five years compared to -42.70% drop over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
Here are Merck & Co Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.33. Likewise, its price to free cash flow for the trailing twelve months is 20.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.40, a number that is poised to hit 1.53 in the next quarter and is forecasted to reach 9.70 in one year’s time.
Technical Analysis of Merck & Co Inc (MRK)
Looking closely at Merck & Co Inc (NYSE: MRK), its last 5-days average volume was 9.47 million, which is a jump from its year-to-date volume of 8.78 million. As of the previous 9 days, the stock’s Stochastic %D was 26.01%. Additionally, its Average True Range was 1.93.
During the past 100 days, Merck & Co Inc’s (MRK) raw stochastic average was set at 0.56%, which indicates a significant decrease from 1.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.05% in the past 14 days, which was lower than the 24.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $114.07, while its 200-day Moving Average is $122.71. However, in the short run, Merck & Co Inc’s stock first resistance to watch stands at $108.28. Second resistance stands at $110.22. The third major resistance level sits at $111.27. If the price goes on to break the first support level at $105.29, it is likely to go to the next support level at $104.24. Should the price break the second support level, the third support level stands at $102.30.
Merck & Co Inc (NYSE: MRK) Key Stats
With a market capitalization of 269.55 billion, the company has a total of 2,532,806K Shares Outstanding. Currently, annual sales are 60,115 M while annual income is 365,000 K. The company’s previous quarter sales were 16,112 M while its latest quarter income was 5,455 M.
